US FDA, EMEA look to harmonise postmarketing surveillance

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2007年 / 1152卷 / 1期
关键词：
Public Health; European Commission; Risk Management; Regulatory Agency; Information Sharing;
D O I：
10.2165/00128415-200711520-00003
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [31] POSTMARKETING SURVEILLANCE IN SPAIN
    CAPELLA, D
    CABEZA, L
    VIDAL, X
    IBANEZ, L
    LAPORTE, JR
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 158 - 158
  • [32] POSTMARKETING SURVEILLANCE STUDIES
    FLETCHER, AP
    BRITISH MEDICAL JOURNAL, 1992, 305 (6847): : 257 - 257
  • [33] Postmarketing surveillance of gabapentin
    Reactions Weekly, 2002, 926 (1) : 5 - 5
  • [34] THE DEMISE OF POSTMARKETING SURVEILLANCE
    FLETCHER, AP
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1995, 14 (01): : 7 - 9
  • [35] POSTMARKETING DRUG SURVEILLANCE
    FELDMANN, EG
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (12) : R1 - R1
  • [36] POSTMARKETING DRUG SURVEILLANCE
    BORDEN, EK
    GARDNER, JS
    WESTLAND, MM
    GARDNER, SD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (06): : 729 - 729
  • [37] An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System
    Kathryn Marwitz
    S. Christopher Jones
    Cindy M. Kortepeter
    Gerald J. Dal Pan
    Monica A. Muñoz
    Drug Safety, 2020, 43 : 457 - 465
  • [38] POSTMARKETING SURVEILLANCE OF IUDS
    KESSEL, E
    CHI, IC
    FELDBLUM, P
    CONTRACEPTIVE DELIVERY SYSTEMS, 1982, 3 (3-4) : 574 - 574
  • [39] CONCERNS WITH POSTMARKETING SURVEILLANCE
    NORVELL, MJ
    ANDERSON, RJ
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1984, 41 (01): : 54 - &
  • [40] POSTMARKETING SURVEILLANCE OF ENALAPRIL
    ROSE, AJ
    JOURNAL OF THE ROYAL COLLEGE OF GENERAL PRACTITIONERS, 1987, 37 (304): : 514 - 514
12345